Slowing of the Inactivation of Cardiac Voltage-Dependent Sodium Channels by the Amiodarone Derivative 2-Methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015)
Slowing of the Inactivation of Cardiac Voltage-Dependent Sodium Channels by the Amiodarone Derivative 2-Methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015)
复制标题
胺碘酮衍生物 2-甲基-3-(3,5-二碘-4-羧甲氧基苄基)苯并呋喃 (KB130015) 减缓心脏电压依赖性钠通道失活
DOI:
10.1124/jpet.102.042218
复制
发表时间:
2003
影响因子:
3.5
通讯作者:
K. Mubagwa
中科院分区:
文献类型:
--
作者:
R. Mačianskienė;S. Viappiani;K. Sipido;K. Mubagwa
2-Methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015 or KB) is a new drug, structurally related to amiodarone and to thyroid hormones. Its effects on cardiac voltage-dependent Na+current (I Na) were studied in pig single ventricular myocytes at 22°C using the whole-cell (with [Na+]i = [Na+]o = 10 mM) and cell-attached patch-clamp techniques. KB markedly slowedI Na inactivation, due to the development of a slow-inactivating component (τslow ≈ 50 ms) at the expense of the normal, fast-inactivating component (τfast ≈ 2–3 ms). The effect was concentration-dependent, with a half-maximally effective concentration (K 0.5) of 2.1 μM. KB also slowed the recovery from inactivation and shifted the voltage-dependent inactivation (ΔV 0.5 = −15 mV;K 0.5 ≥ 6.9 μM) and activation to more negative potentials. Intracellular cell dialysis with 10 μM KB had marginal or no effect on inactivation and did not prevent the effect of extracellularly applied drug. In cell-attached patches, extracellular KB prolonged Na+ channel opening. Amiodarone (10 μM) and 10 μM 3,5,-diiodo-l-thyropropionic acid had no effect on inactivation and did not prevent KB effects. 3,3′,5-Triodo-l-thyronine (T3) also had no effect on inactivation, but at 10 μM it increasedI Na amplitude and partially prevented the slowing of inactivation by KB. These data suggest the existence of a binding site for KB and T3 on Na+ channels.
登录
查看更多内容
DOI:
10.1016/s1050-1738(01)00116-5
发表时间:
2001
期刊:
Trends in cardiovascular medicine.
影响因子:
--
作者:
Balser,JR
通讯作者:
Balser,JR
影响因子:
5
作者:
Maltsev, VA;Sabbah, HN;Undrovinas, AI
通讯作者:
Undrovinas, AI
DOI:
--
发表时间:
1994-08
期刊:
The Journal of pharmacology and experimental therapeutics
影响因子:
--
作者:
H. Tatebayashi;T. Narahashi
通讯作者:
H. Tatebayashi;T. Narahashi
DOI:
--
发表时间:
1987
期刊:
The Journal of pharmacology and experimental therapeutics
影响因子:
--
作者:
Follmer,CH;Aomine,M;Yeh,JZ;Singer,DH
通讯作者:
Singer,DH